ES2099102T3 - Peptidos con accion antagonista de la bradiquinina. - Google Patents

Peptidos con accion antagonista de la bradiquinina.

Info

Publication number
ES2099102T3
ES2099102T3 ES91106663T ES91106663T ES2099102T3 ES 2099102 T3 ES2099102 T3 ES 2099102T3 ES 91106663 T ES91106663 T ES 91106663T ES 91106663 T ES91106663 T ES 91106663T ES 2099102 T3 ES2099102 T3 ES 2099102T3
Authority
ES
Spain
Prior art keywords
bradiquinine
peptides
equivalent
amino acid
sub
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106663T
Other languages
English (en)
Inventor
Gerhard Dr Breipohl
Stephan Dr Henke
Jochen Dr Knolle
Bernward Prof Dr Scholkens
Franz Dr Hock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2099102T3 publication Critical patent/ES2099102T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

PEPTIDOS DE LA FORMULA I EN DONDE 4 EQUIVALE A HIDROGENO, ALQUILO, ALCANOILO, ALCOXICARBONICO, ALQUILSULFONILO, ACLOALQUILO, ARILSULFONICO, HETEROACIDO O UN AMINOACIDO , QUE PUEDE SER SUSTITUIDO. B ES UN AMINOACIDO, C EQUIVALE A UN DI-O TRIPEPTIDO. E EQUIVALE A UN RADICAL DE UN ACIDO ALIFATICO O ALICICLO-ALIFATICO. F EQUIVALE INDEPENDIENTEMENTE DE OTROS IGUALMENTE A UN AMINOACIDO SUSTITUIDO EN LA CADENA LATERAL O A UN ENLACE QUIMICO DIRECTO. G ES UN AMINOACIDO, F'' ESTA DEFINIDA COMO F, PUEDE EQUIVALER A -I ES -OH, -NH SUB 2 ONHC SUB 2 H SUB 5 Y K EQUIVALE A UN RADICAL -NH RECTO, TIENEN UNA REACCION BRADIQUININA ANTAGONICA. SU UTILIZACION TERAPEUTICA ENGLOBA A TODOS LOS ESTADOS PATOLOGICOS, LA CUAL SE INTERVIENE, SE DESENCADENA O SE APOYA A TRAVES DE BRADIQUININAS Y BRADIQUININOS PEPTIDOS ELABORADOS, LOS PEPTIDOS DE LA FORMULA I SE ELABORAN A PARTIR DEL CONOCIDO METODO DE SINTESIS DE PEPTIDOS.
ES91106663T 1990-04-26 1991-04-25 Peptidos con accion antagonista de la bradiquinina. Expired - Lifetime ES2099102T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4013270A DE4013270A1 (de) 1990-04-26 1990-04-26 Peptide mit bradykinin-antagonistischer wirkung

Publications (1)

Publication Number Publication Date
ES2099102T3 true ES2099102T3 (es) 1997-05-16

Family

ID=6405107

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106663T Expired - Lifetime ES2099102T3 (es) 1990-04-26 1991-04-25 Peptidos con accion antagonista de la bradiquinina.

Country Status (25)

Country Link
EP (1) EP0455133B1 (es)
JP (1) JP2552402B2 (es)
KR (1) KR100195569B1 (es)
CN (1) CN1034416C (es)
AT (1) ATE149519T1 (es)
AU (1) AU641004B2 (es)
CA (1) CA2041268C (es)
CY (1) CY2113B1 (es)
CZ (1) CZ280682B6 (es)
DE (2) DE4013270A1 (es)
DK (1) DK0455133T3 (es)
ES (1) ES2099102T3 (es)
FI (1) FI109541B (es)
GR (1) GR3023172T3 (es)
HK (1) HK1006843A1 (es)
HU (1) HU208028B (es)
IE (1) IE911387A1 (es)
IL (1) IL97944A (es)
LV (1) LV10290B (es)
NO (1) NO300779B1 (es)
NZ (1) NZ237928A (es)
PT (1) PT97466B (es)
RU (1) RU2056432C1 (es)
SK (1) SK279286B6 (es)
ZA (1) ZA913121B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU660683B2 (en) * 1991-04-01 1995-07-06 Cortech, Inc. Bradykinin antagonists
TW199863B (es) * 1991-12-21 1993-02-11 Hoechst Ag
TW258739B (es) * 1992-04-04 1995-10-01 Hoechst Ag
CA2184824A1 (en) * 1994-03-09 1995-09-14 Val S. Goodfellow Bradykinin antagonist peptides incorporating n-substituted glycines
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung

Also Published As

Publication number Publication date
DE59108573D1 (de) 1997-04-10
PT97466B (pt) 1998-08-31
EP0455133B1 (de) 1997-03-05
PT97466A (pt) 1992-01-31
CA2041268A1 (en) 1991-10-27
AU641004B2 (en) 1993-09-09
LV10290B (en) 1995-08-20
NZ237928A (en) 1993-09-27
FI911978L (fi) 1991-10-27
HU208028B (en) 1993-07-28
KR910018405A (ko) 1991-11-30
NO300779B1 (no) 1997-07-21
FI109541B (fi) 2002-08-30
CN1034416C (zh) 1997-04-02
NO911649L (no) 1991-10-28
CY2113B1 (en) 2002-04-26
DE4013270A1 (de) 1991-10-31
HU911392D0 (en) 1991-10-28
HUT60286A (en) 1992-08-28
EP0455133A2 (de) 1991-11-06
ATE149519T1 (de) 1997-03-15
SK279286B6 (sk) 1998-09-09
CS9101165A2 (en) 1991-12-17
JP2552402B2 (ja) 1996-11-13
GR3023172T3 (en) 1997-07-30
HK1006843A1 (en) 1999-03-19
JPH04225997A (ja) 1992-08-14
IE911387A1 (en) 1991-11-06
DK0455133T3 (da) 1997-08-25
AU7530491A (en) 1991-11-07
FI911978A0 (fi) 1991-04-24
CZ280682B6 (cs) 1996-04-17
RU2056432C1 (ru) 1996-03-20
IL97944A (en) 1995-05-26
NO911649D0 (no) 1991-04-25
ZA913121B (en) 1992-02-26
CA2041268C (en) 2001-10-02
KR100195569B1 (ko) 1999-06-15
CN1056105A (zh) 1991-11-13
EP0455133A3 (en) 1992-01-08
IL97944A0 (en) 1992-06-21
LV10290A (lv) 1994-10-20

Similar Documents

Publication Publication Date Title
ES2117123T3 (es) Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina.
TR200000482T2 (tr) N-Aroilfenilalanin türevleri.
DK0399731T4 (da) Azaindener
DE69106493D1 (de) Sulfonische Stilbenderivate zur Behandlung von Viruserkrankungen.
DE10299047I1 (de) Sulfonamide ihre Herstellung und Verwendung als Heilmittel und Zwischenprodukte
SV1999000059A (es) Compuestos farmaceuticos casa n.g. 1327
ES2115756T3 (es) Derivados de acido sulfonico utilizados en el tratamiento de enfermedades virales.
ATA16597A (de) Neue substituierte p-sulfonylaminobenzol- sulfonsäureamide
ES2099102T3 (es) Peptidos con accion antagonista de la bradiquinina.
FR2282426A2 (fr) Nouveaux agents sulfones, pour la protection contre les rayons actiniques et compositions cosmetiques les contenant
ES2101073T3 (es) Nuevos aza-androstano-derivados 17-beta-substituidos.
ES2150914T3 (es) Preparacion de factor ix.
MX9301882A (es) Derivados de imidazol, su procedimiento de preparacion y su aplicacion en terapeutica.
EP0245669A3 (en) Pharmaceutical preparation for preventing damage to living cells by free radicals, or for increasing the efficacy of organic sulphur compounds, and process for increasing the life span of isolated organs
BR9910936A (pt) Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
ES2188667T3 (es) 2',5'-oligoadenilatos de fosforotioato/fosfodiester y sus usos antivirales.
ES2039659T3 (es) Procedimiento de reduccion electrolitica de iones ferricos en iones ferrosos en una solucion.
ES2148561T3 (es) Prevencion y curacion de enfermedades alergicas de tipo i.
HRP20000749B1 (hr) Pročišćavanje karboksaldehida
ATE140389T1 (de) Hämoglobin-oligomer basierte komposition und seine herstellung
ES2071862T3 (es) Reduccion e inhibicion del contenido de etu (etilenurea) en alquilenbisditiocarbamatos.
RU96122110A (ru) Способ деструкции адамсита
ES8801902A1 (es) Un procedimiento para la preparacion de agentes inotropicos de quinolona
DE60008621D1 (de) Sauggreifer

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 455133

Country of ref document: ES